GV and Tyson Ventures invested in an $18m funding round for Clear Labs that has now raised $62m altogether from backers also including Dentsu and Tencent.

Continental Grain-backed RNA material producer GreenLight Biosciences is hoping to supply ingredients for RNA-based coronavirus vaccines after securing $17m in funding.

Immune cell mapping technology developer Immunai has emerged from stealth to commercialise inventions from Stanford and PICI labs.

Intel Capital has invested at least $132m in 12 companies so far this year and is on its way to putting between $300m and $500m into startups by the end of 2020.

The Harvard motor neurone disease drug developer secured Mitsui, Sanford Biosciences and existing backer Amgen Ventures for its series A round.

Dai-ichi Life Insurance, Essential Pharma and Medi-Future were among the investors in a round that brought the pre-clinical drug developer's funding haul to $33.1m.

University of Tokyo and Keio University joined multiple corporates in a round that brought the pre-clinical drug developer's funding haul to $33.1m.

The Harvard motor neurone disease drug developer secured the return of Amgen Ventures for its series A round.

The Johns Hopkins University-founded wound evaluation software developer had counted Tencent and Penn Medicine among its backers.

A host of corporate investors including BIVF, Axa Venture Partners and New York Life Ventures invested to bring prescription adherence app developer Wellth's total to $17.1m.